Northstar Neuroscience, the Seattle-based maker of a electrical brain stimulation device for depression, said today that Nawzer Mehta has resigned his job as vice president of clinical and regulatory affairs to pursue another opportunity. Mehta will be replaced by Deborah Sheffield, the company’s director of regulatory affairs. Northstar has switched its strategy to concentrate on depression after its device failed to restore arm movement for stroke patients in a large clinical trial.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
